Vinson; Gavin Paul

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vinson; Gavin Paul.The latest application filed is for "synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions".

Company Profile

0.9.10

Vinson; Gavin Paul - London GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal antibody variable regions Grant 9,422,369 - Vinson , et al. August 23, 2	2016-08-23
Synthetic scFv Analogue To The 6313/G2 (Anti Angiotensin II Type 1 Receptor) Monoclonal Antibody Variable Regions App 20140127205 - Vinson; Gavin Paul ; et al.	2014-05-08
Therapeutic Uses of Monoclonal Antibodies to the Angiotensin-II Type-1 Receptor App 20130202604 - Vinson; Gavin Paul ; et al.	2013-08-08
Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal antibody variable regions Grant 8,487,082 - Vinson , et al. July 16, 2	2013-07-16
Therapeutic uses of monoclonal antibodies to the angiotensin-II type 1 receptor Grant 8,383,108 - Vinson , et al. February 26, 2	2013-02-26
Therapeutic Uses Of Monoclonal Antibodies To The Angiotensin-II Type 1 Receptor App 20110256139 - Barker; Stewart ; et al.	2011-10-20
Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor Grant 7,951,904 - Barker , et al. May 31, 2	2011-05-31
Synthetic scFv Analogue To The 6313/G2 (Anti Angiotensin II Type 1 Receptor) Monoclonal Antibody Variable Regions App 20110081350 - Vinson; Gavin Paul ; et al.	2011-04-07
Use of steroid derivatives for the treatment of angiotensin ll related disease e.g. cardiovascular and proliferative disorders App 20070142341 - Lester; John Wilbraham ; et al.	2007-06-21
Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor App 20060034839 - Barker; Stewart ; et al.	2006-02-16
Cancer treatment Grant 6,852,316 - Vinson , et al. February 8, 2	2005-02-08
Type I angiotensin II receptor specific monoclonal antibodies and hybridomas Grant 6,805,864 - Vinson , et al. October 19, 2	2004-10-19
Cancer treatment App 20020119142 - Vinson, Gavin Paul ; et al.	2002-08-29
Type I angiotensin II receptor specific monoclonal antibodies and hybridomas Grant 6,063,620 - Vinson , et al. May 16, 2	2000-05-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.